Unigene Laboratories has hired a chief financial officer as it continues its quest to develop its product pipeline and bring firmer financial footing to the biotechnology company, particularly in reducing its $43 million debt. David Moskowitz, previously worked as a senior sell-side equity analyst at Roth Capital Partners where he covered Big Pharma companies for […]
Celgene (NYSE:CELG) has acquired cancer drug developer Avila Therapeutics in a deal valued up to $925 million if milestones are reached. Avila’s therapeutic platform involves the development of covalent drugs, which latch onto or bond with target cells and effectively neutralize those cells. Avila’s lead therapeutic, AVL-292, is a lymphoma and autoimmune drug in phase […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A company formed to develop protein therapeutics to treat lysosomal storage diseases — rare genetic disorders that affect the metabolism of certain natural biological substances in cells — is raising $5 million in a series A financing round, according to a filing with the U.S. Securities and Exchange Commission With the investment, the company is […]
Dr. Maria Maccecchini, the CEO of QR Pharmaceuticals in Berwyn, Pennsylvania, is poised to accept the 2011 Iris Newman award for her work as a serial entrepreneur in biotechnology, a career that has spanned more than 20 years. The award will be presented by the Alliance of Women Entrepreneurs on Nov. 14. Maccecchini’s work has […]